How a $600M jolt could get OHSU's promising AIDS vaccine to market
June 14, 2018
A Portland Business Journal cover story profiles the creation of TomegaVax, Vir Biotechnology, and a promising HIV vaccine that started with research at OHSU’s Vaccine & Gene Therapy Institute.